Stephen L. Hauser
Affiliations: | University of California, San Francisco, San Francisco, CA |
Area:
NeuroimmunologyWebsite:
http://www.msgenes.ucsf.edu/faculty.htmlGoogle:
"Stephen Hauser"Mean distance: 14.63 (cluster 3) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zamecnik CR, Sowa GM, Abdelhak A, et al. (2024) An autoantibody signature predictive for multiple sclerosis. Nature Medicine |
Zamecnik CR, Sowa GM, Abdelhak A, et al. (2023) A Predictive Autoantibody Signature in Multiple Sclerosis. Medrxiv : the Preprint Server For Health Sciences |
Ma Q, Shams H, Didonna A, et al. (2023) Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes. Communications Biology. 6: 342 |
Didonna A, Canto Puig E, Ma Q, et al. (2020) Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America |
Ramesh A, Schubert RD, Greenfield AL, et al. (2020) A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America |
Hauser SL, Bar-Or A, Cohen JA, et al. (2020) Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine. 383: 546-557 |
Caverzasi E, Cordano C, Zhu AH, et al. (2020) Imaging correlates of visual function in multiple sclerosis. Plos One. 15: e0235615 |
Hauser SL, Kappos L, Arnold DL, et al. (2020) Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension. Neurology |
Hauser SL, Cree BAC. (2020) Treatment of Multiple Sclerosis: A Review. The American Journal of Medicine |
Schleimer E, Pearce J, Barnecut A, et al. (2020) A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. Journal of Medical Internet Research. 22: e15605 |